Diagnosis dan Tata Laksana Hydroa Vacciniforme
DOI:
https://doi.org/10.55175/cdk.v51i5.902Kata Kunci:
Diagnosis, fotodermatosis, hydroa vacciniforme, tata laksanaAbstrak
Hydroa acciniforme (HV) merupakan fotodermatosis langka dengan awitan tersering pada masa anak-anak. Hingga saat ini patogenesis HV belum diketahui pasti. Penyakit ini merupakan spektrum dengan gejala klinis hampir serupa, namun dengan prognosis sangat berbeda. HV klasik memiliki prognosis paling baik, tetapi berdampak negatif pada kualitas hidup akibat skar, sedangkan hydroa vacciniforme-like lymphoma (HVLL) merupakan varian dengan prognosis paling buruk. Diagnosis HV perlu dipikirkan sebagai diagnosis banding, khususnya pada kasus fotodermatosis dengan awitan masa anak-anak. HV klasik sangat penting dibedakan dari hydroa vacciniforme-like lymphoproliferative disorders (HVLPD) terkait prognosis. Sampai saat ini belum tersedia konsensus atau panduan diagnosis dan tata laksana untuk HV.
Unduhan
Referensi
Vandergriff T. Hydroa vacciniforme. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al, editors. Fitzpatrick’s dermatology. 9th Ed. McGraw-Hill Education; 2019. p. 1634–7.
Chen CC, Chang KC, Medeiros LJ, Lee JYY. Hydroa vacciniforme and hydroa vacciniforme-like lymphoproliferative disorder: A spectrum of disease phenotypes associated with ultraviolet irradiation and chronic epstein–barr virus infection. Int J Mol Sci. 2020;21:9314.
Quintanilla-Martinez L, Fend F. Deciphering hydroa vacciniforme. Blood 2019;133:2735–7.
Wang X, Liang Y, Yang Y, Li W, Wang G, Wang S, et al. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China. J Dermatol. 2021;48(9):1315–26.
Departemen Dermatologi dan Venereologi Rumah Sakit Cipto Mangunkusumo (DV RSCM). Data kasus rawat inap dan rawat jalan Departemen DV RSCM tahun 2013-2021. Jakarta; 2022
Huggins RH, Leithauser LA, Eide MJ, Hexsel CL, Jacobsen G, Lim HW. Quality of life assessment and disease experience of patient members of a web-based hydroa vacciniforme support group. Photodermatol Photoimmunol Photomed. 2009;25(4):209-15
Nahhas AF, Oberlin DM, Braunberger TL, Lim HW. Recent developments in the diagnosis and management of photosensitive disorders. Am J Clin Dermatol. 2018;19:707–31.
Verneuil L, Gouarin S, Comoz F, Agbalika F, Creveuil C, Varna M, et al. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: An assessment of seven adult patients with long-term follow-up. Br J Dermatol. 2010;163(1):174–82.
Hirai Y, Yamamoto T, Kimura H, Ito Y, Tsuji K, Miyake T, et al. Hydroa vacciniforme is associated with increased numbers of epstein-barr virus-infected γδT cells. J Invest Dermatol. 2012;132:1401–8.
Miyake T, Iwatsuki K, Hirai Y, Yamamoto T, Hamada T, Fujii K, et al. The aim of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites. J Med Virol. 2020;92:3689–96.
Hamel R, Mohammad TF, Chahine A, Joselow A, Vick G, Radosta S, et al. Comparison of racial distribution of photodermatoses in USA academic dermatology clinics: A multicenter retrospective analysis of 1080 patients over a 10-year period. Photodermatol Photoimmunol Photomed. 2020;36(3):233–40.
Rutter KJ, Ashraf I, Cordingley L, Rhodes LE. Quality of life and psychological impact in the photodermatoses: A systematic review. Br J Dermatol. 2020;182:1092–102.
Cohen JI, Manoli I, Dowdell K, Krogmann TA, Tamura D, Radecki P, et al. Hydroa vacciniforme-like lymphoproliferative disorder: An EBV disease with a low risk of systemic illness in whites. Blood 2019;133:2753-64.
Gru AA, Jaffe ES. Cutaneous EBV-related lymphoproliferative disorders. Semin Diagn Pathol. 2017;34:60–75.
Jiang AJ, Lim HW. Phototherapy in the evaluation and management of photodermatoses. Dermatol Clin. 2020;38:71–7
Young AR. Principles of phototherapy. In: Griffiths C, Barker J, Bleiker T, Chalmers R, Creamer D, editors. Rook’s textbook of dermatology. 9th Ed. West Sussex: Wiley Blackwell; 2016. p. 21.7
Ren F, Zhu J, Perry DM, Pruitt L, Elston DM. Hydroa vacciniforme-like lymphoproliferative disorder: A retrospective cohort study of seven pediatric cases. Int J Dermatol. 2020;59:e290–2.
Xie Y, Wang T, Wang L. Hydroa vacciniforme-like lymphoproliferative disorder: A study of clinicopathology and whole-exome sequencing in Chinese patients. J Dermatol Sci. 2020;99:128–34.
Hue SSS, Oon ML, Wang S, Tan SY, Ng SB. Epstein–Barr virus-associated T-and NK-cell lymphoproliferative diseases: An update and diagnostic approach. Pathology 2020;52:111–27.
Liu Y, Ma C, Wang G, Wang L. Hydroa vacciniforme–like lymphoproliferative disorder: Clinicopathologic study of 41 cases. J Am Acad Dermatol. 2019;81:534–40.
Chen CC, Chang KC, Jeffrey Medeiros L, Yu-Yun Lee J. Hydroa vacciniforme and hydroa vacciniforme-like t-cell lymphoma: An uncommon event for transformation. J Cutan Pathol. 2016;43(12):1102-11.
Wen PF, Zhang M, Wang TT, Liu HJ, Zhang WY, Liu WP, et al. Comparative study of the clinical pathology, immunophenotype, epstein-barr virus infection status, and gene rearrangements in adult and child patients with hydroa vacciniforme-like lymphoproliferative disorder. Am J Dermatopathol. 2019;41(1):7-15.
Adler BL, DeLeo VA. Actinic prurigo and hydroa vacciniforme. Curr Derm Rep. 2019;8:63–72.
Ruan Y, Shen X, Shi R, Zhao X, Zheng J. Hydroa vacciniforme-like lymphoproliferative disorder treated with intravenous immunoglobulin: Longterm remission without haematopoietic stem cell transplantation or chemotherapy. Acta Derm Venereol. 2020;100:1–2.
Guo N, Chen Y, Wang Y, Huang Y, Feng Y, Li M, et al. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: An analysis of prognostic implications and treatment based on 19 cases. Diagn Pathol. 2019;14(1):82
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2024 Reisa Reshinta, Githa Rahmayunita, Rahadi Rihatmadja, Rinadewi Astriningrum
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
